NCT05415787Completed
Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.
Evaluation of the Technical Feasibility of Testing Circulating Tumour DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.
Source: ClinicalTrials.gov · Last updated 1 Mar 2024
Brief summary (registry, in English)
Evaluation of technical feasibility for Homologous Recombination (HR) genes variants research on circulating tumor DNA (ctDNA) from plasma and urine of patients with a metastatic prostate cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 40 (actual)
- First submitted
- 8 Jun 2022
- Start date
- 18 Aug 2022
- Primary completion date
- 17 Jan 2024
- Lead sponsor
- University Hospital, Tours
- Diseases
- Prostate cancer
- NCT number
- NCT05415787
What you commit to
- Study type: Observational
- Participants enrolled: 40
- From 18 Aug 2022 to the primary completion date, 17 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Age \> 18 years
- Metastatic prostate cancer
- Archived tissue sample available for testing for somatic variants of HRR genes (including BRCA1/BRCA2)
- Free, informed and signed consent for research
- Non inclusion criteria
- Refusal of blood and urine collection
- Patient cognitively incapable of signing consent to participate in this study
- Patient under guardianship or curatorship
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University hospital Coordinator of this site? Confirm its status | Tours | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.